Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-15 Purchase | 2026-06-17 6:24 pm | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 67,669 | $24.97 | $1,689,818 | 7,808,627 (Indirect) | View |
| 2026-05-19 Purchase | 2026-05-21 4:20 pm | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 4,798 | $24.96 | $119,776 | 7,740,958 (Indirect) | View |
| 2026-05-12 Purchase | 2026-05-14 5:21 pm | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 6,387 | $24.9 | $159,036 | 7,736,160 (Indirect) | View |
| 2026-05-07 Purchase | 2026-05-11 5:44 pm | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 51,258 | $24.75 | $1,268,594 | 7,729,773 (Indirect) | View |
| 2026-05-04 Purchase | 2026-05-06 7:16 pm | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. RA Capital Nexus Fund IV L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2,840,429 | $18.39 | $52,222,946 | 6,314,525 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-05-14 4:05 pm | N/A N/A | Hemab Therapeutics Holdings Inc. | COAG | AI DEN-MAB LLC AI Biotechnology LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 0 | $0 | 4,876,344 (Direct) | View |
| 2026-05-04 Conversion | 2026-05-06 7:16 pm | N/A N/A | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. RA Capital Nexus Fund IV L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 5,057,999 | $0 | 6,314,525 (Indirect) | View |
| 2026-05-04 Conversion | 2026-05-06 4:55 pm | N/A N/A | Hemab Therapeutics Holdings Inc. | COAG | Novo Holdings A/S 10% Owner | 4,370,575 | $0 | 4,180,550 (Direct) | View |
| 2026-01-29 Option Award | 2026-05-04 4:20 pm | N/A 2036-01-28 | Hemab Therapeutics Holdings Inc. | COAG | MARAGANORE JOHN Director | 107,338 | $0 | 143,286 (Direct) | View |
| 2026-05-04 Conversion | 2026-05-04 4:20 pm | N/A N/A | Hemab Therapeutics Holdings Inc. | COAG | MARAGANORE JOHN Director | 19,608 | $0 | 143,286 (Direct) | View |
| 2026-01-29 Option Award | 2026-05-04 4:18 pm | N/A 2036-01-28 | Hemab Therapeutics Holdings Inc. | COAG | Madigan Catherine Chief Medical Officer | 194,150 | $0 | 194,150 (Direct) | View |
| 2026-01-29 Option Award | 2026-05-04 4:16 pm | N/A 2036-01-28 | Hemab Therapeutics Holdings Inc. | COAG | Behrndt-Eriksen Mads Nikolaj See Remarks | 244,222 | $0 | 244,222 (Direct) | View |
Ownership | 2026-04-30 6:37 pm | N/A N/A | Hemab Therapeutics Holdings Inc. | COAG | Novo Holdings A/S 10% Owner | 0 | $0 | 4,180,550 (Direct) | View |
Ownership | 2026-04-30 6:36 pm | N/A N/A | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. RA Capital Nexus Fund IV L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 0 | $0 | 4,838,086 (Indirect) | View |
Ownership | 2026-04-30 6:30 pm | N/A N/A | Hemab Therapeutics Holdings Inc. | COAG | MARAGANORE JOHN Director | 0 | $0 | 280,984 (Direct) | View |
Ownership | 2026-04-30 6:23 pm | N/A 2036-01-04 | Hemab Therapeutics Holdings Inc. | COAG | Murthy Ananthram Sreenivasa Chief Operating Officer | 0 | $0 | 245,036 (Direct) | View |
Ownership | 2026-04-30 6:22 pm | N/A 2032-03-20 | Hemab Therapeutics Holdings Inc. | COAG | Bain Linda Director | 0 | $0 | 65,340 (Direct) | View |
Ownership | 2026-04-30 6:21 pm | N/A N/A | Hemab Therapeutics Holdings Inc. | COAG | Behrndt-Eriksen Mads Nikolaj See Remarks | 0 | $0 | 511,830 (Indirect) | View |
Ownership | 2026-04-30 6:18 pm | N/A 2034-05-07 | Hemab Therapeutics Holdings Inc. | COAG | Vaishnaw Akshay Director | 0 | $0 | 65,340 (Direct) | View |
Ownership | 2026-04-30 6:18 pm | N/A 2035-02-09 | Hemab Therapeutics Holdings Inc. | COAG | Madigan Catherine Chief Medical Officer | 0 | $0 | 310,376 (Direct) | View |
Ownership | 2026-04-30 6:17 pm | N/A 2031-02-01 | Hemab Therapeutics Holdings Inc. | COAG | Sorensen Benny See Remarks | 0 | $0 | 1,715,186 (Direct) | View |